Marker Therapeutics, Inc. (MRKR)
2.00
-0.07
(-3.38%)
USD |
NASDAQ |
Jan 09, 16:00
2.05
+0.05
(+2.50%)
After-Hours: 20:00
Marker Therapeutics Price: 2.00 for Jan. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ADMA Biologics, Inc. | 17.95 |
| Viridian Therapeutics, Inc. | 31.75 |
| Neurocrine Biosciences, Inc. | 135.79 |
| Kiniksa Pharmaceuticals International Plc | 42.67 |
| AIM ImmunoTech, Inc. | 1.29 |
Price Related Metrics
| PS Ratio | 5.423 |
| PEG Ratio | -0.1191 |
| Price to Book Value | 1.813 |
| Earnings Yield | -61.45% |
| Market Cap | 33.35M |
| PEGY Ratio | -0.1191 |